Skip to main content
AAPL+0.64%MSFT+1.07%NVDA+0.64%GOOGL+0.80%AMZN+1.46%SPCX+1.27%TSM+0.81%AVGO+3.64%META+0.81%TSLA+0.74%LLY-2.33%WMT-0.13%AMD+5.31%SKHY-0.11%JPM-1.77%BRK-B-2.07%MU+1.55%V-0.37%JNJ-2.15%XOM-3.97%MA-0.37%ASMLa+1.94%ABBV-2.33%COST-1.21%1398.HK-0.22%0700.HK-6.09%KO-0.71%CVX-4.74%PG-0.83%CSCO+2.18%0939.HK-0.14%ORCL-0.97%3988.HK-0.04%GE+0.52%BAC-1.07%HD-0.40%1816.HK-26.27%0857.HK-1.46%UNH-10.21%1288.HK-1.27%PM-0.85%0005.HK-1.87%NVS-2.46%HSBA.L-2.00%INTC-0.91%MS-1.29%AMAT+0.88%AP2d+2.23%AZN-1.93%TXN-1.16%AUDJPY-1.66%AUDUSD-1.51%EURAUD+1.03%AUDCHF-1.00%AUDNZD-0.98%AUDCAD-0.97%GBPAUD+0.96%GBPJPY-0.71%NZDJPY-0.71%CADJPY-0.70%EURJPY-0.67%CHFJPY-0.66%AUDSGD-0.63%AUDDKK-0.58%USDCAD+0.55%USDCHF+0.53%GBPUSD-0.53%NZDUSD-0.53%EURUSD-0.50%AUDNOK-0.47%GBPTRY+0.41%NZDMXN+0.39%USDMXN+0.32%GBPHKD+0.32%USDZAR+0.30%GBPMXN-0.28%USDTHB+0.25%EURZAR+0.24%GBPZAR+0.22%USDTRY+0.21%USDJPY-0.18%CHFNOK+0.17%USDILS+0.16%USDNOK+0.15%USDCNH-0.13%NOKJPY-0.11%CHFSEK+0.10%EURNOK+0.10%EURCNH-0.10%USDPLN+0.09%USDSEK+0.09%NZDSGD+0.09%GBPSGD-0.07%EURHKD-0.06%USDDKK+0.05%EURGBP+0.05%EURCAD+0.05%EURSGD-0.05%PLNJPY-0.05%SGDJPY+0.05%EURSEK+0.04%EURCZK+0.04%USDCOP-0.04%EURCHF+0.04%EURPLN+0.04%EURNZD+0.03%NZDCHF-0.03%CADCHF-0.02%CHFSGD+0.02%USDHKD-0.01%GBPCHF-0.01%USDSGD+0.01%GBPCAD-0.01%NZDCAD0.00%GBPNZD0.00%EURDKK0.00%W1-0.76%XNGUSD-0.61%C1-0.55%UKOIL+0.52%S1-0.39%USOIL+0.32%XAUUSD+0.24%GAUUSD+0.24%XPTUSD-0.22%XAGUSD+0.20%GAGUSD+0.20%COTTON+0.15%BTCUSD-3.51%ETHUSD+57.77%USDTUSD-0.02%XRPUSD+52.58%SOLUSD+57.55%TRXUSDT+0.77%ZECUSDT-6.76%XMRUSDT-1.71%DOGEUSD+55.95%LINKUSD-3.40%XLMUSD-3.79%BCHUSDT-3.59%LTCUSD+47.50%UNIUSD-3.05%SUIUSD-3.20%TONUSD+59.18%HBARUSDT-5.05%TAOUSDT-3.41%AAVEUSD-3.74%ONDOUSDT-5.51%ICPUSDT-2.22%DOTUSDT-3.90%WLDUSDT-3.57%ARBUSDT-5.68%ATOMUSDT-2.50%INJUSDT-7.97%STXUSDT-3.10%PYTHUSDT-0.76%TIAUSDT-3.37%FETUSDT-4.46%JUPUSDT+0.25%SEIUSDT-4.48%GRTUSDT-3.56%OPUSDT-3.90%IOTAUSDT-2.66%POLUSDT-2.10%WIFUSDT-2.98%AXSUSDT-2.91%EOSUSDT-4.24%IMXUSDT-3.36%FARTCOINUSDT-6.54%GALAUSDT-2.38%DYDXUSDT-2.63%ORDIUSDT-2.62%NOTUSDT+0.86%RONINUSDT-2.92%AAPL+0.64%MSFT+1.07%NVDA+0.64%GOOGL+0.80%AMZN+1.46%SPCX+1.27%TSM+0.81%AVGO+3.64%META+0.81%TSLA+0.74%LLY-2.33%WMT-0.13%AMD+5.31%SKHY-0.11%JPM-1.77%BRK-B-2.07%MU+1.55%V-0.37%JNJ-2.15%XOM-3.97%MA-0.37%ASMLa+1.94%ABBV-2.33%COST-1.21%1398.HK-0.22%0700.HK-6.09%KO-0.71%CVX-4.74%PG-0.83%CSCO+2.18%0939.HK-0.14%ORCL-0.97%3988.HK-0.04%GE+0.52%BAC-1.07%HD-0.40%1816.HK-26.27%0857.HK-1.46%UNH-10.21%1288.HK-1.27%PM-0.85%0005.HK-1.87%NVS-2.46%HSBA.L-2.00%INTC-0.91%MS-1.29%AMAT+0.88%AP2d+2.23%AZN-1.93%TXN-1.16%AUDJPY-1.66%AUDUSD-1.51%EURAUD+1.03%AUDCHF-1.00%AUDNZD-0.98%AUDCAD-0.97%GBPAUD+0.96%GBPJPY-0.71%NZDJPY-0.71%CADJPY-0.70%EURJPY-0.67%CHFJPY-0.66%AUDSGD-0.63%AUDDKK-0.58%USDCAD+0.55%USDCHF+0.53%GBPUSD-0.53%NZDUSD-0.53%EURUSD-0.50%AUDNOK-0.47%GBPTRY+0.41%NZDMXN+0.39%USDMXN+0.32%GBPHKD+0.32%USDZAR+0.30%GBPMXN-0.28%USDTHB+0.25%EURZAR+0.24%GBPZAR+0.22%USDTRY+0.21%USDJPY-0.18%CHFNOK+0.17%USDILS+0.16%USDNOK+0.15%USDCNH-0.13%NOKJPY-0.11%CHFSEK+0.10%EURNOK+0.10%EURCNH-0.10%USDPLN+0.09%USDSEK+0.09%NZDSGD+0.09%GBPSGD-0.07%EURHKD-0.06%USDDKK+0.05%EURGBP+0.05%EURCAD+0.05%EURSGD-0.05%PLNJPY-0.05%SGDJPY+0.05%EURSEK+0.04%EURCZK+0.04%USDCOP-0.04%EURCHF+0.04%EURPLN+0.04%EURNZD+0.03%NZDCHF-0.03%CADCHF-0.02%CHFSGD+0.02%USDHKD-0.01%GBPCHF-0.01%USDSGD+0.01%GBPCAD-0.01%NZDCAD0.00%GBPNZD0.00%EURDKK0.00%W1-0.76%XNGUSD-0.61%C1-0.55%UKOIL+0.52%S1-0.39%USOIL+0.32%XAUUSD+0.24%GAUUSD+0.24%XPTUSD-0.22%XAGUSD+0.20%GAGUSD+0.20%COTTON+0.15%BTCUSD-3.51%ETHUSD+57.77%USDTUSD-0.02%XRPUSD+52.58%SOLUSD+57.55%TRXUSDT+0.77%ZECUSDT-6.76%XMRUSDT-1.71%DOGEUSD+55.95%LINKUSD-3.40%XLMUSD-3.79%BCHUSDT-3.59%LTCUSD+47.50%UNIUSD-3.05%SUIUSD-3.20%TONUSD+59.18%HBARUSDT-5.05%TAOUSDT-3.41%AAVEUSD-3.74%ONDOUSDT-5.51%ICPUSDT-2.22%DOTUSDT-3.90%WLDUSDT-3.57%ARBUSDT-5.68%ATOMUSDT-2.50%INJUSDT-7.97%STXUSDT-3.10%PYTHUSDT-0.76%TIAUSDT-3.37%FETUSDT-4.46%JUPUSDT+0.25%SEIUSDT-4.48%GRTUSDT-3.56%OPUSDT-3.90%IOTAUSDT-2.66%POLUSDT-2.10%WIFUSDT-2.98%AXSUSDT-2.91%EOSUSDT-4.24%IMXUSDT-3.36%FARTCOINUSDT-6.54%GALAUSDT-2.38%DYDXUSDT-2.63%ORDIUSDT-2.62%NOTUSDT+0.86%RONINUSDT-2.92%
XP

Xenon Pharmaceuticals Inc. (XENE)

NASDAQ • Healthcare

$37.75
-$1.03 (-2.7%)
Market closed

Last close at November 18, 2026 at 21:00 UTC

Open$38.48
Day Range$37.65 - $39.72
Avg. Volume (3M)1.3M
Market Cap$3.7B
52 Week Range
$33.38$72.66

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$428.7M
EPS (TTM)
-$4.7
ROA (TTM)
-35.73%
Current Ratio
21.19

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

0.0%Q2 2026-$1.17
+2.6%Q3 2026-$1.11
+1.8%Q4 2026-$1.11

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Beat +1.8%

Xenon Pharmaceuticals topped the EPS estimate in the second fiscal quarter of 2026, reported on August 6, based on preliminary results, with EPS of $-1.11 against a $-1.14 estimate, +2.6%. The company said net income was a loss of about $110.7 million, down 30.7% from a loss of $84.7 million a year ago, while EPS improved to $-1.11 from $-1.07 a year earlier, a 3.7% decline. Operating income came in at about negative $123.2 million, and operating cash flow was negative $95.4 million. Consensus for the next period calls for EPS of $-1.17 on revenue of $1.3 million.

View full earnings history

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc. develops ion channel-targeted medicines for neurological disorders as a clinical-stage biotechnology company listed on the NASDAQ Global Market under ticker XENE. Founded in 1996 and based in Burnaby, British Columbia, Xenon centers its pipeline on experimental therapies for epilepsy, developmental and epileptic encephalopathies, and pain.

Name
Xenon Pharmaceuticals Inc.
CEO
Ian C. Mortimer
Industry
Healthcare
Year Founded
1996
Employees
364

Today's Snapshot

AI-generated

The day ended with XENE 2.7% lower at 37.75, in line with a weaker sector. Xenon Pharmaceuticals discussed its epilepsy drug launch at a Jefferies healthcare conference.

Trading Volume

Below 10d avg (1.3M)

1.2M

vs S&P 500 Today

Underperforming Market

-2.40%

Updated: November 18, 2026 at 21:23 UTC

Technical Indicators

1 Buy2 Neutral5 Sell
XENE presents a cautious sell profile: trend strength is muted with an ADX around 21, while momentum indicators are mixed—RSI in the mid-40s and a barely positive MACD contrast with negative short-term momentum. The stock, trading near 37.75, sits below most short- and longer-term averages and the classic pivot at 38.83 is overhead, suggesting resistance. Volatility is modest with an ATR near $1.50, and on-balance volume shows a negative cumulative level despite a buy signal, indicating uneven buying pressure. Technical takeaway: Sell—lack of trend strength and price below key moving averages.
All signals
  • EMA (5 indicators)$38.91 - $47.61
    Sell
  • RSI (14)43.77
    Neutral
  • Stochastic %K (14, 3, 3)38.01
    Neutral
  • MACD Level (12, 26)0.02
    Buy
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.